We are live on ! Find out more
SRTA

Strata Critical Medical Inc

114 hedge funds and large institutions have $107M invested in Strata Critical Medical Inc in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 41 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 10

38% more call options, than puts

Call options by funds: $568K | Put options by funds: $411K

12% more funds holding

Funds holding: 102114 (+12)

1.08% more ownership

Funds ownership: 48.61%49.69% (+1.1%)

17% less capital invested

Capital invested by funds: $128M → $107M (-$21.3M)

27% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 41

Holders
114
Holders Change
+12
Holders Change %
+11.76%
% of All Funds
1.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
30
Reduced
41
Closed
10
Calls
$568K
Puts
$411K
Net Calls
+$157K
Net Calls Change
-$233K
Name Holding Trade Value Shares
Change
Change in
Stake
AG
51
Algert Global
California
$99K +$107K +34,838 New
CSB
52
City State Bank
Iowa
$98K +$106K +34,400 New
CG
53
Caprock Group
Idaho
$88.3K
SWP
54
Stratos Wealth Partners
Ohio
$87.5K +$94.7K +30,705 New
Deutsche Bank
55
Deutsche Bank
Germany
$86K -$4.27K -1,384 -4%
LPL Financial
56
LPL Financial
California
$85.7K -$24.2K -7,849 -21%
HighTower Advisors
57
HighTower Advisors
Illinois
$85K -$910 -295 -1%
AIG
58
American International Group
New York
$84.6K -$787 -255 -0.9%
Mirae Asset Global Investments
59
Mirae Asset Global Investments
South Korea
$74K +$71.6K +23,195 New
NL
60
NKCFO LLC
Illinois
$71K
PCM
61
Prelude Capital Management
New York
$68.7K +$74.4K +24,100 New
Wells Fargo
62
Wells Fargo
California
$66K +$8.26K +2,676 +13%
Royal Bank of Canada
63
Royal Bank of Canada
Ontario, Canada
$66K -$64.5K -20,890 -48%
Manulife (Manufacturers Life Insurance)
64
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$62.5K -$8K -2,592 -11%
CSS
65
Cubist Systematic Strategies
Connecticut
$61.9K +$67K +21,729 New
Marshall Wace
66
Marshall Wace
United Kingdom
$60.7K +$65.8K +21,314 New
New York State Common Retirement Fund
67
New York State Common Retirement Fund
New York
$59.7K -$676 -219 -1%
SG Americas Securities
68
SG Americas Securities
New York
$59K -$34K -11,029 -35%
BHCM
69
Brevan Howard Capital Management
Jersey
$58K +$62.8K +20,340 New
BRWA
70
B. Riley Wealth Advisors
Florida
$56.6K +$27.8K +9,000 +70%
Bank of Montreal
71
Bank of Montreal
Ontario, Canada
$55.9K
VOYA Investment Management
72
VOYA Investment Management
Georgia
$55.4K -$17.1K -5,549 -22%
MIM
73
MetLife Investment Management
New Jersey
$47.5K -$48.3K -15,661 -48%
T. Rowe Price Associates
74
T. Rowe Price Associates
Maryland
$46K +$1.75K +566 +4%
HF
75
HRT Financial
New York
$45K -$87.5K -28,363 -64%

SRTA Hedge Fund Activity: Q1 2024 in Review

114 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q1 2024, worth a combined $107M — down 17% from $128M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new SRTA positions and 10 closed out — a net gain of 12 holders — while 30 added to existing stakes and 41 trimmed.

The largest buyer was AWM Investment Company, adding an estimated $2.31M. The largest seller was Morgan Stanley, cutting an estimated $4.76M.

  • 114 institutional investors held Strata Critical Medical Inc (SRTA) as of Q1 2024, up from 102 in Q4 2023.
  • Funds reported $107M of Strata Critical Medical Inc stock for Q1 2024, down 17% quarter-over-quarter.
  • 22 funds opened new Strata Critical Medical Inc positions in Q1 2024 and 10 closed out, a net change of +12 holders.
  • The largest Strata Critical Medical Inc buyer in Q1 2024 was AWM Investment Company, an estimated $2.31M added.
  • The largest Strata Critical Medical Inc seller in Q1 2024 was Morgan Stanley, an estimated $4.76M sold.

Based on aggregated 13F filings for Q1 2024.